Adherence to Antithrombotic Therapy Guidelines in COVID-19 Patients at a Major Medical Center in West Virginia
West Virginia Medical Journal · 01.03.2024 · 20
DOI: 10.21885/wvmj.2024.04 ↗Kurz gefasst
Leitlinie in der Zeitschrift West Virginia Medical Journal, online erschienen am 01.03.2024. Verfasst von Saranya Dinesan und 10 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION Guidelines for the appropriate use of antithrombotics in hospitalized patients diagnosed with the coronavirus disease of 2019 (COVID-19) in the non-intensive care unit (ICU) setting have been published. Adherence to these guidelines was evaluated at the Charleston Area Medical Center (CAMC) in West Virginia. METHODS In a retrospective study, data from patients treated from February 1, 2022, to July 10, 2022, and entered into the CAMC COVID-19 registry were reviewed. Exclusionary criteria included treatment in an ICU, and those with comorbidities that would justify the use of unfractionated heparin. Collected data included patient demographics, comorbidities, and treatments related to antithrombotic therapy. RESULTS There were 512 patients in the registry. Of those, 76.56% received non-ICU care, with 255 remaining for analysis after other exclusionary criteria were applied. Subjects were assigned to two groups based on antithrombotic guideline adherence: Group A (58.82%) received treatment consistent with guidelines, and Group B (41.18%) did not. DISCUSSION Despite published guidelines specific to this patient population, there were missed opportunities to better manage antithrombotic therapies in this high-risk and complex patient population. CONCLUSION Our study results revealed the majority of patients in a non-ICU setting received treatment consistent with guidelines. As part of a teaching institution, we are responsible for leading by example by utilizing published guidelines established to improve the quality of care. The results of this project justify a comprehensive quality improvement initiative around antithrombotic guideline adherence in COVID-19 and other complex conditions.
Zitieren
APA
Dinesan, S., MBBS, Kali, M. A., BS, Jubelirer, S. J., MD, Davis, E., RN, EdD, Welch, C. A., & MS (2024). Adherence to Antithrombotic Therapy Guidelines in COVID-19 Patients at a Major Medical Center in West Virginia. West Virginia Medical Journal, 20. https://doi.org/10.21885/wvmj.2024.04
Vancouver
Dinesan S, MBBS, Kali MA, BS, Jubelirer SJ, MD, et al. Adherence to Antithrombotic Therapy Guidelines in COVID-19 Patients at a Major Medical Center in West Virginia. West Virginia Medical Journal. 2024:20. doi:10.21885/wvmj.2024.04
BibTeX
@article{Dinesan2024,
author = {Dinesan, Saranya and MBBS and Kali, Mohammad Ali and BS and Jubelirer, Steven J. and MD and Davis, Elaine and RN and EdD and Welch, Christine A. and MS},
title = {Adherence to Antithrombotic Therapy Guidelines in COVID-19 Patients at a Major Medical Center in West Virginia},
journal = {West Virginia Medical Journal},
year = {2024},
pages = {20},
doi = {10.21885/wvmj.2024.04}
}
EUVIMED